Bare Metal Stent    Trends in Acute Reperfusion Therapy for St-Segment Elevation Myocardial Infarction from 1999 to 2006: We Are Getting Better but We Have Got a Long Way to Go Eur Heart J (2008) 29;609-17 K. A. Eagle, et al. Increased Late Mortality after Sirolimus-Eluting Stents Versus Bare-Metal Stents in Diseased Saphenous Vein Grafts: Results from the Randomized Delayed Rrisc Trial J Am Coll Cardiol (2007) 50;261-7 P. Vermeersch, et al. Offsetting Impact of Thrombosis and Restenosis on the Occurrence of Death and Myocardial Infarction after Paclitaxel-Eluting and Bare Metal Stent Implantation Circulation (2007) 115;2842-7 G. W. Stone, et al. A Pooled Analysis of Data Comparing Sirolimus-Eluting Stents with Bare-Metal Stents N Engl J Med (2007) 356;989-97 C. Spaulding, et al. Randomized Comparative Trial of a Thin-Strut Bare Metal Cobalt-Chromium Stent Versus a Sirolimus-Eluting Stent for Coronary Revascularization Catheter Cardiovasc Interv (2007) 69;790-8 P. Ortolani, et al. Randomized Trial of Sirolimus-Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction (Sesami) J Am Coll Cardiol (2007) 49;1924-30 M. Menichelli, et al. Coronary Collateral Function Long after Drug-Eluting Stent Implantation J Am Coll Cardiol (2007) 49;15-20 P. Meier, et al. Comparison of Drug-Eluting Stents with Bare Metal Stents in Unselected Patients with Acute Myocardial Infarction Catheter Cardiovasc Interv (2007) 70;1-8 L. I. Kupferwasser, et al. Analysis of 14 Trials Comparing Sirolimus-Eluting Stents with Bare-Metal Stents N Engl J Med (2007) 356;1030-9 A. Kastrati, et al. Transition from Bare Metal to Drug Eluting Stenting in Contemporary Us Practice: Effect on Incidence and Predictors of Clinically Driven Target Lesion Revascularization Catheter Cardiovasc Interv (2007) 70;175-83 M. Jonas, et al. Influence of a Pressure Gradient Distal to Implanted Bare-Metal Stent on in-Stent Restenosis after Percutaneous Coronary Intervention Circulation (2007) 116;2802-8 L. O. Jensen, et al. Outcomes of Stent Thrombosis and Restenosis During Extended Follow-up of Patients Treated with Bare-Metal Coronary Stents Circulation (2007) 116;2391-8 B. Doyle, et al. Effectiveness of Drug-Eluting Stents in Patients with Bare-Metal in-Stent Restenosis: Meta-Analysis of Randomized Trials J Am Coll Cardiol (2007) 49;616-23 A. Dibra, et al. The Long-Term Value of Sirolimus- and Paclitaxel-Eluting Stents over Bare Metal Stents in Patients with Diabetes Mellitus Eur Heart J (2007) 28;26-32 J. Daemen, et al. Relocation of Minimal Luminal Diameter after Bare Metal and Drug-Eluting Stent Implantation: Incidence and Impact on Angiographic Late Loss Catheter Cardiovasc Interv (2007) 69;181-8 M. A. Costa, et al. Serial Angioscopic Evidence of Incomplete Neointimal Coverage after Sirolimus-Eluting Stent Implantation: Comparison with Bare-Metal Stents Circulation (2007) 116;910-6 M. Awata, et al. Unrestricted Use of Drug-Eluting Stents Compared with Bare-Metal Stents in Routine Clinical Practice: Findings from the National Heart, Lung, and Blood Institute Dynamic Registry J Am Coll Cardiol (2007) 50;2029-36 J. D. Abbott, et al.